10-K: Ensign Group Reports Strong 2025 Growth, Strategic Acquisitions

The Ensign Group, Inc. reported an 18.7% increase in total revenue for 2025, driven by strategic acquisitions and improved occupancy in its skilled nursing and senior living facilities.

Summary

• Total revenue increased by $797.4 million, or 18.7%, to $5,057.8 million for the year ended December 31, 2025, compared to 2024.
• Net income attributable to The Ensign Group, Inc. rose to $343.971 million in 2025 from $297.973 million in 2024.
• Diluted GAAP earnings per share (EPS) grew to $5.84 in 2025 from $5.12 in 2024.
• The company acquired 46 new operations in 2025, adding 4,175 operational skilled nursing beds and 313 operational senior living units.
• Same Facilities occupancy increased by 2.5% to 82.9% in 2025, while Transitioning Facilities occupancy increased by 4.2% to 84.2%.
• Skilled services revenue increased by $761.0 million, or 18.7%, compared to 2024, driven by strong occupancy and skilled mix performance.
• Standard Bearer Healthcare REIT, Inc. (captive REIT) added $314.2 million of real estate assets in 2025, growing its portfolio to approximately $1.7 billion fair value.
• The company donated $10.0 million to Insignia Pathway in November 2025, bringing total donations to $45.0 million since its formation in 2024.
• A class action lawsuit for alleged wage, hour, or labor code-related violations in California was settled for $12.0 million in 2025, pending court approval.
• The company repurchased $20.0 million of common stock in 2025 under a program approved in February 2025, and a new $20.0 million repurchase program was approved in May 2025.

Sentiment

Score: 8

Explanation: StockSavvy.ai views this as a strong performance, with significant revenue and earnings growth driven by successful acquisitions and operational improvements, despite a complex and evolving regulatory environment. The company's strategic focus on high-acuity patients and real estate expansion is yielding positive results.

Positives

• Total revenue increased by $797.4 million, or 18.7%, to $5,057.8 million in 2025, demonstrating strong top-line growth.
• Net income attributable to The Ensign Group, Inc. increased to $343.971 million in 2025, reflecting enhanced profitability.
• Diluted GAAP EPS grew to $5.84 in 2025, indicating improved shareholder value.
• The company successfully expanded its operations by acquiring 46 new facilities, adding 4,175 skilled nursing beds and 313 senior living units.
• Occupancy rates improved significantly, with Same Facilities occupancy increasing by 2.5% to 82.9% and Transitioning Facilities occupancy rising by 4.2% to 84.2%.
• Skilled mix by nursing days increased to 30.7% and by nursing revenue to 49.4%, indicating a successful shift towards higher-acuity patients with better reimbursement rates.
• Medicare daily rates at Same Facilities and Transitioning Facilities increased by 5.0% and 5.2%, respectively, and average Medicaid rates increased by 4.6%.
• Standard Bearer REIT's real estate portfolio expanded by $314.2 million, reaching a fair value of approximately $1.7 billion, enhancing long-term asset value.
• Cash provided by operating activities increased by $217.1 million to $564.270 million in 2025, reflecting strong operational cash generation.
• The company has consistently increased its dividend every year for the last 23 years, demonstrating a commitment to shareholder returns.
• Management concluded that internal control over financial reporting was effective as of December 31, 2025, indicating sound financial governance.
• Expansion into new states (Alabama, Alaska, and Oregon) in Q1 2025 broadens the company's geographic footprint.
• The company added over 6,700 full-time equivalent team members, a 17% increase, supporting operational growth and stability.

Negatives

• Interest income decreased by $4.2 million, primarily due to the utilization of cash for real estate purchases.
• General and administrative expense increased by $44.7 million, or 19.8%, driven by additional headcount related to acquisition activities.
• Depreciation and amortization expense increased by $20.2 million, or 24.0%, due to newly acquired operations and capital investments.
• Cash used in investing activities increased by $123.1 million to $513.177 million, primarily for acquisitions and capital expenditures.
• Cash used in financing activities increased by $9.6 million, mainly due to share repurchases.
• The effective tax rate increased to 24.4% in 2025 from 22.7% in 2024.

Risks

• Changes to Medicare and Medicaid rules, including reductions of reimbursement rates, changes to spending requirements, and data reporting standards, could have a material, adverse effect on revenues, financial condition, and results of operations.
• State-level direct spending requirements could negatively impact operational results and increase non-compliance risks.
• Changes to the U.S. healthcare system, including new regulations, transparency, and potential spending levels, continue to impose new requirements that could materially impact the business.
• Anticipated changes in the U.S. political environment, including those from the current Presidential administration and Congress, may result in significant changes to the regulatory framework, enforcements, and reimbursements.
• The company is subject to various government reviews, audits, and investigations that could adversely affect its business, including refund obligations, criminal charges, fines, and loss of licensure or participation in Medicare/Medicaid programs.
• Public and government calls for increased survey and enforcement efforts toward SNFs, and past/potential rulemaking resulting in enhanced enforcement and penalties, could increase scrutiny by state and federal survey agencies.
• CMS’s changes to the Special Focus Facility (SFF) program and its three-year look-back period may create greater risk of facilities being subject to fines and sanctions, even after graduating from the program.
• Future cost containment initiatives undertaken by private third-party payors may limit revenue and profitability.
• Reductions in Medicare reimbursements for physician and non-physician services could impact reimbursement for medical professionals.
• The company may be subject to increased investigation and enforcement activities related to HIPAA violations.
• Security breaches and other cyber-security incidents could violate security laws and subject the company to significant liability.
• The company may not be fully reimbursed for all services for which each facility bills through consolidated billing, which could adversely affect revenue, financial condition, and results of operations.
• Increased competition for, or a shortage of, nurses and other skilled personnel could increase staffing and labor costs and subject the company to monetary fines.
• Annual caps, uncertainty regarding reimbursement, and other cost-reductions for outpatient therapy services may reduce future revenue and profitability or cause losses.
• Increased scrutiny of activities and billing practices by the OIG or other regulatory authorities may result in increased monitoring, decreased reimbursement, or other adverse effects.
• State efforts to regulate or deregulate the healthcare services industry or the construction/expansion of healthcare facilities could impair the ability to expand operations or result in increased competition.
• Newly enacted legislation in states where independent subsidiaries are located may impact the volume and exposure in claims filed and the overall cost of those cases from a defense and indemnity standpoint.
• Changes to federal and state employment-related laws and regulations could increase the cost of doing business.
• Required regulatory approvals could delay or prohibit transfers of healthcare operations, resulting in periods of non-reimbursement.
• Compliance with federal and state fair housing, fire, safety, and other regulations may require unanticipated and costly expenditures.
• Revenue, financial condition, and results of operations could be negatively impacted by any changes in the acuity mix of patients, payor mix, and payment methodologies.
• The company is subject to litigation that could result in significant legal costs and large settlement amounts or damage awards, and changes in arbitration enforceability may affect these risks.
• Regular internal investigations detecting noncompliance could materially decrease revenue.
• The California Office of Health Care Affordability (OHCA) Cost and Market Impact Review (CMIR) has the potential to delay, prevent proposed transactions, and require disclosure of confidential information.
• The company may be unable to complete future facility or business acquisitions at attractive prices or at all, or may elect to dispose of underperforming subsidiaries, either of which could decrease revenue.
• Inability to successfully integrate acquired facilities and businesses into operations, or exposure to unforeseen costs, liabilities, and regulatory issues from acquisitions.
• Failure to achieve or maintain competitive quality of care ratings from CMS or private organizations could negatively affect the business.
• Inability to obtain insurance, or increased cost of insurance, could adversely affect the business, and self-insurance programs may expose the company to significant and unexpected costs and losses.
• Geographic concentration of independent subsidiaries (Arizona, California, Texas) could leave the company vulnerable to economic downturns, regulatory changes, or acts of nature in those areas.
• Actions of a national labor union that has pursued a negative publicity campaign criticizing the business in the past may adversely affect revenue and profitability.
• Risks associated with leased real property, including lease termination, lease extensions, and special charges, could adversely affect the business.
• Failure to generate sufficient cash flow to cover required payments or meet operating covenants under long-term debt, mortgages, and long-term operating leases could result in defaults and cross-defaults.
• A continued housing slowdown or downturn could decrease demand for senior living services.
• Unsuccessful identification and consummation of real estate asset acquisitions as the company expands its real estate portfolio.
• Expansion into other relevant healthcare industries would subject the company to risks in markets with limited experience.
• If referral sources fail to view the company as an attractive skilled nursing provider, or refer fewer patients, the patient base may decrease.
• The company may need additional capital to fund growth, which may not be available on acceptable terms, limiting growth.
• Delays in reimbursement may cause liquidity problems.
• The utilization and expansion of managed care organizations (MCOs) may contribute to delays or reductions in reimbursement, including Managed Medicaid.
• Compliance with Department of Housing and Urban Development (HUD) regulations may require unanticipated expenditures.
• Failure to safeguard patient trust funds may subject the company to citations, fines, and penalties.
• As a holding company with no operations, reliance on multiple independent subsidiaries to generate revenue and funds, with potential for liabilities of one subsidiary to be imposed on others.
• Implementation of a new enterprise resource planning (ERP) system may adversely affect business, results of operations, or the effectiveness of internal controls over financial reporting.
• Conflicts of interest may arise due to certain directors serving on both Ensign and Pennant boards, and executive officers owning Pennant common stock.
• Standard Bearer's failure to remain qualified as a REIT may cause it to be subject to U.S. federal income tax, and legislative actions affecting REITs could have a negative effect.
• Failure to comply with existing environmental laws could result in increased expenditures, litigation, and potential loss to the business and asset value.

Future Outlook

The company plans to continue its growth strategy by expanding its talent base, increasing the mix of higher acuity patients, focusing on organic growth and operating efficiencies, acquiring additional operations in existing and new markets, and expanding/renovating existing facilities. It also intends to strategically invest in and integrate other post-acute care healthcare businesses. The company anticipates lower overall occupancy in years of significant growth due to the acquisition of operations with lower initial occupancy and skilled mix, but expects newly acquired underperforming facilities to become accretive to earnings within 12 to 18 months. Approximately $190.0 million is budgeted for renovation projects in 2026. The company believes its current cash balances, operating cash flow, and available financing will be sufficient to cover operating needs for at least the next 12 months. The full effect of the One Big Beautiful Bill (OBBB) on state budgets and Medicaid reimbursement remains uncertain, potentially increasing the risk of lower SNF reimbursement rates. Regulatory scrutiny from the OIG and CMS, including new audits and evaluations, is expected to continue. The implementation of new data standards and APIs, as well as changes to telehealth flexibilities and the long-stay antipsychotic measure, will require ongoing monitoring and adaptation.

Management Comments

• We believe we exist to dignify and transform post-acute care.
• Our results serve as a strong indicator that our strategy is working and our transformation is underway.
• Our dedication to our cultural and operational fundamentals continues to deliver strong results.
• Our strength remains in our operating model, which empowers each operator to form their own market-specific strategy and adjust to the needs of their local medical communities, including methods for attracting new healthcare professionals into our workforce and retaining and developing existing staff.
• As we continue to execute on core fundamentals, we continue to see positive trends on both turnover and agency usage across our operations.
• We expect the REIT structure to allow us to better demonstrate the growing value of our owned real estate and provide us with an efficient vehicle for future acquisitions of properties that could be operated by our independent subsidiaries or other third parties.
• We believe our current cash balances, our cash flow from operations and the amounts available for borrowing under our Credit Facility will be sufficient to cover our operating needs for at least the next 12 months.
• We believe that an appropriate allowance has been recorded for the possibility of these receivables proving uncollectible and continually monitors and adjusts these allowances as necessary.
• We believe that we are in material compliance with applicable environmental and occupational health and safety requirements.

Industry Context

StockSavvy.ai notes that the post-acute care industry is benefiting from an aging population, increasing life expectancies, and a shift towards lower-cost care settings, which aligns with Ensign's focus on skilled nursing and senior living. The industry remains highly fragmented, presenting ongoing acquisition and consolidation opportunities that Ensign is actively pursuing. The shift towards value-based care and reimbursement reform is a significant trend, and Ensign's strong clinical outcomes position it well to be rewarded under these new models. However, the industry faces continuous regulatory changes, including those from the One Big Beautiful Bill (OBBB) and evolving Medicare/Medicaid rules, which introduce uncertainty regarding funding and operational requirements. Labor shortages and rising costs are also persistent industry challenges.

Comparison to Industry Standards

• The company's average score on the Overall Star Rating on the CMS Five-Star Quality Rating System for all facilities is 6.8% better than the national average, indicating superior quality of care compared to industry benchmarks.
• The average quality measure (QM) rating for all facilities is 18.2% better than the national average, further highlighting strong performance in clinical outcomes.
• The company's skilled mix by nursing days of 30.7% and by nursing revenue of 49.4% suggests a focus on higher-acuity patients, which generally command higher reimbursement rates compared to lower-acuity patient mixes often seen in the broader industry.
• The company's consistent track record of improving acquired facilities, with EBITDAR as a percentage of revenue improving from 13.2% during the first three months of operations to 18.8% during the 45th quarter of operation, demonstrates a robust operational turnaround capability that likely surpasses many industry peers for distressed assets.
• The company's growth in operational skilled nursing beds (37,911 in 2025) and senior living units (3,402 in 2025) through significant acquisitions (145 facilities from 2021-2025) indicates an aggressive expansion strategy in a fragmented market, potentially outpacing smaller regional competitors and some larger national providers.
• The average consolidated occupancy rate for skilled nursing facilities of 82.2% in 2025 is a key metric for comparison against industry peers like National Healthcare Corporation or Omega Healthcare Investors' tenants, though direct comparable data is not provided in the filing.

Corporate Governance

Legal Proceedings

• Settled substantially all alleged wage, hour, or labor code-related violations asserted on a class or representative basis against California independent subsidiaries for $12.0 million in 2025, pending court approval.
• Received a Civil Investigative Demand (CID) from the U.S. Department of Justice (DOJ) in January 2024, investigating whether claims submitted to Medicare and Texas Medicaid for services were unnecessary or inconsistent with reimbursement requirements, covering the period from January 1, 2016, to the present. The company is fully cooperating.
• A jury returned a medical negligence verdict against one of the company's independent subsidiaries in Arizona in late November 2023; the company is in the process of appealing this verdict.
• Resolved a qui tam complaint related to medical director relationships for $48.0 million in 2024, following the DOJ's decision not to intervene in 2020. The settlement did not include admissions of wrongdoing.
• The California Office of Health Care Affordability (OHCA) is conducting a Cost and Market Impact Review (CMIR) regarding a proposed transaction involving three California operations, and issued an investigatory subpoena on October 10, 2025. The company has filed a Petition in the Superior Court of California challenging the CMIR regulations and subpoena.
• As of December 31, 2025, 25 of the company's independent subsidiaries had multi-claim Medicare Revenue Recoupment Reviews scheduled or in process.

Related Party Transactions

• Certain directors serving on the Board of Directors also serve on the board of directors of The Pennant Group, Inc. (Pennant), and ownership of Pennant common stock by directors and executive officers may create, or appear to create, conflicts of interest.
• Standard Bearer Healthcare REIT, Inc. (captive REIT) leases 116 properties to the company's independent subsidiaries. Intercompany rental revenue of $107.6 million from these subsidiaries was eliminated in consolidation.
• Standard Bearer has a management agreement with the Service Center, resulting in management fees of $7.589 million in 2025, which were eliminated in consolidation.
• Standard Bearer obtains funding through intercompany debt arrangements, incurring interest expense of $35.058 million in 2025, which was eliminated in consolidation.
• The Pennant Group, Inc. (Pennant) operates 32 senior living operations leased from the company, generating rental income of $16.497 million in 2025.

Stakeholder Impact

• Shareholders: Positive impact from strong revenue and EPS growth, consistent dividend increases, and stock repurchase programs. Potential negative impact from litigation costs, regulatory risks, and potential delays in transactions due to OHCA.
• Employees: Benefits from increased headcount (6,700 FTEs, 17% increase), robust training and development programs (CEO-in-Training, COO Program, Ensign University), attractive wage and benefits packages, unique incentive programs (stock options, performance bonuses), and a commitment to inclusion through the Unity Committee. Potential negative impact from industry-wide labor shortages and increased competition for skilled personnel, as well as wage-hour litigation.
• Patients/Residents: Benefits from the company's commitment to quality care, evidenced by above-national-average CMS ratings, expansion of facilities and services, focus on high-acuity patients, and social sustainability initiatives through Elevate Charities and Insignia Pathway. Potential negative impact from regulatory deficiencies, staffing shortages, and changes in reimbursement affecting care access.
• Customers (Referral Sources): The company's reputation for high-quality and cost-effective care, coupled with its community-focused approach, aims to attract and retain referrals from hospitals, physicians, and other healthcare providers.
• Suppliers/Creditors: Stable financial performance and strong cash flow from operations support relationships with suppliers and creditors. The company manages significant long-term debt and lease obligations.
• Regulatory Bodies: Continuous engagement with federal and state regulatory authorities through ongoing scrutiny, audits, and investigations (e.g., DOJ CID, OHCA CMIR, Medicare Reviews) indicates a highly regulated operating environment.

Next Steps

• Continue to grow talent base and develop future leaders.
• Increase the overall percentage or mix of higher acuity patients.
• Focus on organic growth and operating efficiencies.
• Continue to acquire additional operations in existing and new markets.
• Expand and renovate existing operations.
• Strategically invest in and integrate other post-acute care healthcare businesses.
• Monitor and advocate for positions that protect the interest of employees, residents, and independent subsidiaries at all levels of government, particularly state and local, regarding regulatory changes.
• Continue to monitor developments related to the One Big Beautiful Bill (OBBB) and its impact on state budgets and Medicaid reimbursement.
• Continue to monitor any changes to the DOJ and FTC's antitrust policies.
• Continue to monitor the implementation of the Interoperability Final Rule and the 42 CFR Part 2 final rule.
• Address the investigatory subpoena from the California OHCA and pursue the Petition in Superior Court to complete the underlying transaction.
• Recognize approximately $102,691 thousand in stock-based compensation expense for unvested options and $49,326 thousand for unvested restricted stock awards in future periods.
• Budgeted approximately $190.0 million for renovation projects in 2026.

Key Dates

Recommendation

The Ensign Group demonstrates robust financial performance with significant revenue and EPS growth, driven by successful strategic acquisitions and strong operational improvements in occupancy and patient acuity. The company's unique decentralized operating model and commitment to quality care provide a competitive advantage in a growing market. While regulatory scrutiny and litigation risks are present, the company has a track record of managing these challenges and its strong cash flow and consistent dividend increases make it an attractive investment for long-term growth.

Keywords

Skilled Nursing, Senior Living, Healthcare Real Estate, REIT, Post-Acute Care, Medicaid, Medicare, Managed Care, Acquisitions, Occupancy, Patient Acuity, Standard Bearer, Ensign Group, Healthcare Services, Compliance, Regulatory Risk, Cybersecurity, Labor Costs, Stock Repurchase, Dividends